Skip to main content
https://pbs.twimg.com/media/FheK5J4WAAwxPg8.jpg
Abs 1507 at #ACR22 demonstrated that even a 6-month delay in PsA dx from symptom onset contributes to worse patient-reported outcomes measures on overall quality of life. @RheumNow https://t.co/qLOwE9rImz https://t.co/nacdjz5pCy
Dr. Rachel Tate
13-11-2022
×